James M. Gower

2012

In 2012, James M. Gower earned a total compensation of $2.3M as Former Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 59% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$382,819
Option Awards$1,240,695
Salary$671,612
Other$5,148
Total$2,300,274

Gower received $1.2M in option awards, accounting for 54% of the total pay in 2012.

Gower also received $382.8K in non-equity incentive plan, $671.6K in salary and $5.1K in other compensation.

Rankings

In 2012, James M. Gower's compensation ranked 3,090th out of 11,487 executives tracked by ExecPay. In other words, Gower earned more than 73.1% of executives.

ClassificationRankingPercentile
All
3,090
out of 11,487
73rd
Division
Manufacturing
1,078
out of 4,253
75th
Major group
Chemicals And Allied Products
242
out of 1,198
80th
Industry group
Drugs
142
out of 920
85th
Industry
Pharmaceutical Preparations
115
out of 700
84th
Source: SEC filing on March 30, 2015.

Gower's colleagues

We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2012.

2012

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2012

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2012

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2012

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

In-depth

You may also like